SCHEMBL14295404

SCHEMBL14295404

c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4ccc5sc6ccccc6c5c4)c4ccccc34)cc2)c2ccc3sc4ccccc4c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.37
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ CYP1A2 P05177 2/20 0.34
▸ PTPN7 P35236 1/20 0.33
▸ DUSP3 P51452 1/20 0.33
▸ PTPN12 Q05209 1/20 0.33
▸ PTPN22 Q9Y2R2 1/20 0.33
▸ MAPT P10636 4/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TDP1 Q9NUW8 2/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ APP P05067 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ F9 P00740 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ PTGIR P43119 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26687128 0.97 GPR3 (0.35) GPR3RXRARXRBCYP1A2PTPN7
SCHEMBL26687120 0.97 GPR3 (0.35) GPR3RXRARXRBCYP1A2PTPN7
SCHEMBL17369901 0.95 GPR3 (0.33) GPR3RXRARXRBCYP1A2PTPN7
SCHEMBL18802623 0.95 GPR3 (0.37) GPR3RXRARXRBCYP1A2PTPN7
SCHEMBL15179916 0.94 RXRA (0.33) GPR3RXRARXRBCYP1A2PTPN7
SCHEMBL21966050 0.94 ALDH1A1 (0.36) GPR3RXRARXRBCYP1A2PTPN7
SCHEMBL15179915 0.93 PIM3 (0.33) GPR3RXRARXRBCYP1A2MAPT
SCHEMBL15179829 0.93 PIM3 (0.33) GPR3RXRARXRBCYP1A2MAPT
SCHEMBL26687482 0.93 KDM4E (0.38) GPR3RXRARXRBCYP1A2PTPN7
SCHEMBL21984080 0.92 GPR3 (0.35) GPR3CYP1A2PTPN7DUSP3PTPN12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME INMT, TYR, ALKBH2 GPR3 3415/4885RXRA 4214/4885RXRB 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback